Pr Christophe Massard

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023. (1 janv. 2025)
• Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials? (1 déc. 2024)
• Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer. (30 oct. 2024)
• The genomic and transcriptomic landscape of metastastic urothelial cancer. (4 oct. 2024)
• Assessing actionability and incidental findings of germline variants in two precision oncology trials. (1 oct. 2024)